Molecular aetiology and pathogenesis of basal cell carcinoma.
Recent insights into the cell biology of the epidermis and its appendages are transforming our understanding of the pathogenesis of basal cell carcinoma (BCC). The significant progress that has been made warrants a comprehensive review of the molecular and cellular pathology of BCC. The items addressed include environmental and genetic risk factors, the biology of the putative precursor cell(s), and the contribution of aberrations in processes such as apoptosis, cell proliferation, differentiation and signalling to carcinogenesis. Furthermore, established and novel treatment modalities are discussed with particular attention to future biological approaches.
Tilli
C M L J
CM
Research Institute of Growth & Development, Department of Dermatology, University of Masstricht, The Netherlands.
Van Steensel
M A M
MA
Krekels
G A M
GA
Neumann
H A M
HA
Ramaekers
F C S
FC
D017209:Apoptosis; D002280:Basal Cell Carcinoma / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D002454:Cell Differentiation; D049109:Cell Proliferation; D004817:Epidermis / Q000378:metabolism / Q000473:pathology; D020022:Genetic Predisposition to Disease; D006801:Humans; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D012307:Risk Factors; D012878:Skin Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D014466:Ultraviolet Rays / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications / Q000473:pathology